Medical tourism – patients travelling internationally for healthcare – is a $100B+ global market that is growing as quality gaps between healthcare systems and cost differences between markets make international healthcare travel economically rational for patients. Medical tourism destination operators, hospital international patient programmes, medical facilitator companies, and health tourism technology platforms are all evaluating new market entry opportunities. GreyRadius helps medical tourism businesses validate patient and referral demand, build international patient pipelines, and raise capital.
Why now? Gulf medical tourism investment is accelerating – Saudi Arabia's Vision 2030 includes a specific medical tourism target, UAE's Cleveland Clinic Abu Dhabi and similar institutions are attracting international patients, and Thailand, India, and Malaysia all have established medical tourism programmes that are scaling. Telehealth is enabling pre-travel consultation that is extending the medical tourism funnel.
$250B+
Global medical tourism market by 2028
Growing at 10% annually as quality and cost gaps between healthcare systems drive patient mobility internationally.
30+
Primary interviews per medical tourism mandate
International patients, referring physicians, and medical facilitators – every engagement grounded in direct primary research.
8 weeks
Market entry strategy delivery
AI-augmented referral network mapping and international patient demand research delivers medical tourism market entry strategies efficiently.
Global medical tourism market is projected to reach $250B by 2028 – growing at 10% annually as quality and cost gaps between healthcare systems drive patient mobility.
Oncology, cardiology, and orthopaedics are the largest medical tourism procedure categories – complex, expensive treatments where quality variation between markets is high and cost differential is significant.
Wellness tourism is growing at 15%+ annually – preventive health, spa, and wellness retreat tourism is expanding as consumers invest in proactive health management through travel.
Digital health is extending the medical tourism funnel – pre-travel teleconsultation, remote monitoring, and digital follow-up care are all making international healthcare more accessible and trustworthy.
If you recognise your situation below, we can help.
International patient demand validation
You need to validate the size and source of international patient demand for your medical speciality and destination, including referring physician networks and insurance payer appetite.
Accreditation and quality certification strategy
You need to understand JCI accreditation, ISO certification, and other quality credentials that are prerequisites for international patient confidence.
International referral and facilitator network development
You need to identify and engage medical facilitator companies, insurance companies, and referring physician networks in source markets.
GTM for a medical tourism operator or hospital
You have a medical tourism programme or international patient department and need a GTM strategy covering source market outreach and patient acquisition.
Raising capital for a medical tourism venture
You are raising investment and need a pitch book grounded in international patient demand data and procedure market sizing.
Digital health integration strategy
You need a telehealth and digital care continuity strategy that extends your medical tourism offering beyond the in-destination episode.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate international patient demand for medical tourism in a new source or destination market. Covers patient surveys, referring physician interviews, insurance payer research, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for medical tourism investments. Covers patient volume modelling, procedure economics, marketing cost, and investor-ready projections.
Learn more →End-to-end market entry for medical tourism operators. Accreditation pathway, referral network development, insurance payer engagement, and first-international-patient milestone.
Learn more →Embedded GTM team for hospital international patient programmes. Facilitator and referral outreach, source market pipeline, and first-patient milestone tracking.
Learn more →Investor-ready pitch books for medical tourism ventures. Patient-demand-validated market sizing, procedure economics, and investor identification.
Learn more →AI use-case prioritisation in medical tourism – from personalised treatment matching and patient journey management to outcome prediction and automated care coordination.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Hospitality · Market Entry
Hospitality · GTM
Hospitality · Feasibility
All three. We work with hospitals on international patient strategy, facilitator companies on market entry and GTM, and wellness tourism operators on market entry and fundraising.
Gulf, Southeast Asia, and South Asia – both as source markets for patients and as destination markets for medical tourism investment.
Typically 8–12 weeks for international patient demand research, accreditation mapping, and referral network strategy.
Yes. Facilitator and referral network identification are part of our market entry execution service.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Gulf, Southeast Asia, South Asia.
